Compassionate use of remdesivir for patients with severe Covid-19

New England Journal of Medicine

Volumn 382, Issue 24, 2020, Pages 2327-2336

  Grein, J ^a   Ohmagari, N ^j   Shin, D ^b   Diaz, G ^p   Asperges, E ^s   Castagna, A ^t   Feldt, T ^y   Green, G ^c   Green, M L ^q   Lescure, F X ^z   Nicastri, E ^u   Oda, R ^k   Yo, K ^l   Quiros Roldan, E ^v   Studemeister, A ^d   Redinski, J ^d   Ahmed, S ^ac   Bernett, J ^f   Chelliah, D ^b   Chen, D ^ad   Chihara, S ^r   Cohen, S H ^g   Cunningham, J ^ae   D'Arminio Monforte A ^t   Ismail, S ^h   Kato, H ^m   Lapadula, G ^w   L'Her E ^aa   Maeno, T ⁿ   Majumder, S ^e   Massari, M ^x   Mora Rillo, M ^af   Mutoh, Y ^o   Nguyen, D ^ab   Verweij, E ^ag   Zoufaly, A ^ah   Osinusi, A O ⁱ   DeZure, A ⁱ   Zhao, Y ⁱ   Zhong, L ⁱ   Chokkalingam, A ⁱ   Elboudwarej, E ⁱ   Telep, L ⁱ   Timbs, L ⁱ   Henne, I ⁱ   Sellers, S ⁱ   Cao, H ⁱ   Tan, S K ⁱ   Winterbourne, L ⁱ   Desai, P ⁱ   Mera, R ⁱ   Gaggar, A ⁱ   Myers, R P ⁱ   Brainard, D M ⁱ   Childs, R ^ai   Flanigan, T ^aj   more..

^a Cedars Sinai Medical Center   (United States)

^b EL CAMINO HOSPITAL   (United States)

^c Santa Rosa Memorial Hospital   (United States)

^d Landstuhl Regional Medical Center   (United States)

^e Good Samaritan Hospital   (United States)

^f John Muir Health   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h NorthBay Medical Center   (United States)

ⁱ GILEAD SCIENCES   (United States)

^j NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^k TOKYO BAY URAYASU ICHIKAWA MEDICAL CENTER   (Japan)

^l Hiratsuka City Hospital   (Japan)

^m YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

ⁿ GUNMA UNIVERSITY HOSPITAL   (Japan)

^o TOSEI GENERAL HOSPITAL   (Japan)

^p Providence Everett Medical Center   (United States)

^q UNIVERSITY OF WASHINGTON   (United States)

^r VIRGINIA MASON MEDICAL CENTER   (United States)

^s FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^t UNIVERSITY OF MILAN   (Italy)

^u NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^v UNIVERSITY OF BRESCIA   (Italy)

^w UNIVERSITY OF MILANO BICOCCA   (Italy)

^x PATHOLOGY UNIT   (Italy)

^y UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^z UNIVERSITÉ PARIS DESCARTES   (France)

^aa BREST UNIVERSITY HOSPITAL   (France)

^ab BORDEAUX UNIVERSITY HOSPITAL   (France)

^ac St Alexius Medical Center Hoffman Estates   (Canada)

^ad Mackenzie Health   (Canada)

^ae NewYork Presbyterian Hospital   (United States)

^af HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^ag BERNHOVEN HOSPITAL   (Netherlands)

^ah KAISER FRANZ JOSEF HOSPITAL   (Austria)

^ai U S PUBLIC HEALTH SERVICE   (United States)

^aj MIRIAM HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

REMDESIVIR; ADENOSINE PHOSPHATE; ALANINE; ANTIVIRUS AGENT;

ADULT; AMBIENT AIR; ARTICLE; ARTIFICIAL VENTILATION; BREATHING; COMPASSIONATE USE; CORONAVIRUS DISEASE 2019; DISEASE SEVERITY; DRUG USE; EXTRACORPOREAL OXYGENATION; EXTUBATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; OXYGEN SATURATION; PRIORITY JOURNAL; SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2; AGED; BETACORONAVIRUS; CANADA; CORONAVIRUS INFECTION; EUROPE; INTRAVENOUS DRUG ADMINISTRATION; JAPAN; MIDDLE AGED; MORTALITY; PANDEMIC; UNITED STATES; VERY ELDERLY; VIRUS PNEUMONIA; YOUNG ADULT;

ADENOSINE MONOPHOSPHATE; ADMINISTRATION, INTRAVENOUS; ADULT; AGED; AGED, 80 AND OVER; ALANINE; ANTIVIRAL AGENTS; BETACORONAVIRUS; CANADA; COMPASSIONATE USE TRIALS; CORONAVIRUS INFECTIONS; EUROPE; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PANDEMICS; PNEUMONIA, VIRAL; RESPIRATION, ARTIFICIAL; UNITED STATES; YOUNG ADULT;

EID: 85086346057     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa2007016     Document Type: Article

References (29)

1. Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed 2020; 91:157-60.
2. Spinelli A, Pellino G. COVID-19 pandemic: perspectives on an unfolding crisis. Br J Surg 2020 March 19 (Epub ahead of print).
3. Fauci AS, Lane HC, Redfield RR. Covid-19 — navigating the uncharted. N Engl J Med 2020;382:1268-9.
4. Mahase E, Kmietowicz Z. Covid-19: doctors are told not to perform CPR on patients in cardiac arrest. BMJ 2020;368: m1282.
5. Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, et al. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis. Travel Med Infect Dis 2020 March 13 (Epub ahead of print).
6. Weiss P, Murdoch DR. Clinical course and mortality risk of severe COVID-19. Lancet 2020;395:1014-5.
7. Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020 March 13 (Epub ahead of print).
8. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 2020 March 23 (Epub ahead of print).
9. Poston JT, Patel BK, Davis AM. Management of critically ill adults with COVID-19. JAMA 2020 March 26 (Epub ahead of print).
10. Cao B, Wang Y, Wen D, et al. A trial of lopinavir–ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 2020; 382:1787-99.
11. Shen C, Wang Z, Zhao F, et al. Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA 2020 March 27 (Epub ahead of print).
12. Touret F, de Lamballerie X. Of chloroquine and COVID-19. Antiviral Res 2020 March 5 (Epub ahead of print).
13. Baden LR, Rubin EJ. Covid-19 — the search for effective therapy. N Engl J Med 2020;382:1851-2.
14. de Wit E, Feldmann F, Cronin J, et al. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A 2020;117:6771-6.
15. Sheahan TP, Sims AC, Graham RL, et al. Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses. Sci Transl Med 2017;9(396):eaal3653.
16. Sheahan TP, Sims AC, Leist SR, et al. Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nat Commun 2020;11:222.
17. Wang M, Cao R, Zhang L, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020;30: 269-71.
18. Mulangu S, Dodd LE, Davey RT Jr, et al. A randomized, controlled trial of Ebola virus disease therapeutics. N Engl J Med 2019;381:2293-303.
19. European Medicines Agency. Summary on compassionate use: Remdesivir Gilead. April3,2020(https://www.ema.europa.eu/en/ documents/other/summary-compassionate -use-remdesivir-gilead_en.pdf).
20. Kujawski SA, Wong KK, Collins JP, et al. First 12 patients with coronavirus disease 2019 (COVID-19) in the United States. medRxiv, March 12, 2020 (https://www.medrxiv.org/content/10.1101/2020.03.09.20032896v1).
21. Holshue ML, DeBolt C, Lindquist S, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med 2020; 382:929-36.
22. Lescure FX, Bouadma L, Nguyen D, et al. Clinical and virological data of the first cases of COVID-19 in Europe: a case series. Lancet Infect Dis 2020 March 27 (Epub ahead of print).
23. Arentz M, Yim E, Klaff L, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020 March 19 (Epub ahead of print).
24. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 2020 February 7 (Epub ahead of print).
25. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 February 24 (Epub ahead of print).
26. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62.
27. Bhatraju PK, Ghassemieh BJ, Nichols M, et al. Covid-19 in critically ill patients in the Seattle region — case series. N Engl J Med 2020;382:2012-22.
28. ICNARC report on COVID-19 in critical care. London: Intensive Care National Audit & Research Centre, March 27, 2020 (https://www.icnarc.org/DataServices/Attachments/Download/b5f59585-5870 -ea11-9124-00505601089b).
29. Zhang C, Shi L, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol 2020 March 4 (Epub ahead of print).